Navigation Links
Global Coronary Stents Industry
Date:12/8/2011

, JNJ and Others (includes

corresponding Graph/Chart) 92

Table 39: Leading Players in Japanese Drug-Eluting Stent

Market (2010) - Percentage Breakdown of Share for Johnson &

Johnson and Boston Scientific (includes corresponding

Graph/Chart) 92

B.Market Analytics 93

Table 40: Japanese Recent Past, Current & Future Analysis

for Coronary Stents by Product Segment - Bare Metal and Drug

Eluting Stent Markets Independently Analyzed with Annual

Sales in US$ Million for years 2009 through 2017 (includes

corresponding Graph/Chart) 93

Table 41: Japanese Recent Past, Current & Future Analysis

for Coronary Stents by Product Segment - Bare Metal and Drug

Eluting Stent Markets Independently Analyzed with Annual

Sales in Thousand Units for years 2009 through 2017

(includes corresponding Graph/Chart) 94

Table 42: Japanese Historic Review for Coronary Stents by

Product Segment - Bare Metal and Drug Eluting Stent Markets

Independently Analyzed with Annual Sales in US$ Million for

years 2003 through 2008 (includes corresponding Graph/Chart) 95

Table 43: Japanese Historic Review for Coronary Stents by

Product Segment - Bare Metal and Drug Eluting Stent Markets

Independently Analyzed with Annual Sales in Thousand Units

for years 2003 through 2008 (includes corresponding

Graph/Chart) 96

Table 44: Japanese 15-Year Perspective for Coronary Stents

by Product Segment - Percentage Breakdown of Dollar Sales

for Bare Metal Stents and Drug Eluting Stents Markets for

years 2003, 2010 & 2017 (includes corresponding Graph/Chart) 97

Table 45: Japanese 15-Year Perspective for Coronary Stents

by Product Segment - Percentage Breakdown of Unit Sales for

Bare Metal Stents and Drug Eluting Stents Markets for years

2003, 2010 & 2017 (includes corresponding Gra
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ) ... Diagnostic Testing Market - Forecasts to 2019: Expected ... and is expected to be valued at USD ... http://photos.prnewswire.com/prnh/20130307/600769 ... segmented according to immunoprotein types which include immunoglobulins, ...
(Date:7/11/2014)... July 11, 2014 ... Safety & Health Expo 2014 were a ... to London , plus ... exhibition.          (Logo: ... )      (Photo: ...
(Date:7/10/2014)... July 11, 2014  Major advances in radiation ... are being highlighted in a three-day Oncology Summit ... from 10-12 July, 2014.  Renowned national and international cancer experts ... practices and exchange knowledge on modern technologies making ... efficient. The Summit will address ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... Aug. 17, 2011 Reportlinker.com announces that ... in its catalogue: Levosimendan ... http://www.reportlinker.com/p0483048/Levosimendan---Comprehensive-patent-search.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Eliminate unnecessary ... patent information. Pipeline Developer is ...
... 16, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... KRYSTEXXA® (pegloticase) Phase III clinical studies in patients with ... The Journal of the American Medical Association ( ... resulted in significant and sustained reductions in uric acid ...
Cached Medicine Technology:Levosimendan - Comprehensive Patent Search 2Levosimendan - Comprehensive Patent Search 3Levosimendan - Comprehensive Patent Search 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 2Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 5Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 6Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 7Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 8
(Date:7/11/2014)... City, UT (PRWEB) July 11, 2014 WWTrek ... work at the Kilimanjaro Kids Community in Tanzania. Opened in ... goats, 150 chickens, and two cows. HOP Founder, Dean Cardinale, ... education for some of the orphaned children he encountered while ... HOP Team visited the children, who have all made astounding ...
(Date:7/11/2014)... Francisco shows that an "expressive therapy" group intervention ... with HIV disclose their health status and improves ... quality of their relationships., "Medication alone is totally ... Machtinger, MD, director of the Women,s HIV Program ... are on effective antiretroviral therapy but far too ...
(Date:7/11/2014)... July 11, 2014 Recently, iFitDress.com, a ... occasion outfits, has released its new collection of ... the company has announced that all these beautiful items ... The deadline of the special offer is July 22. ... major officials pay close attention to customer satisfaction. On ...
(Date:7/11/2014)... July 11, 2014 Organic Crop ... being launched into the limelight over the past decade. ... was once considered to be an alternative food eaten ... are now purchasing organic food.” Organic crop farmers have ... vegetables, grains, nuts and herbs over the past five ...
(Date:7/11/2014)... personalized medicine may be just around the corner, thanks ... Yu and scientists at Massachusetts General Hospital and Harvard ... Science , Yu and her colleagues report how ... streams of six patients. Some of these deadly cancer ... and establish secondary tumors in vital organs such as ...
Breaking Medicine News(10 mins):Health News:Human Outreach Project Sees Incredible Progress in the Kilimanjaro Kids Community 2Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 4
... Beneficial bacteria found in healthy women help to reduce the ... more difficult for the virus to spread, boosting the possibility ... against HIV. , The findings come from physicians and scientists ... Medical Center, who worked together in an effort to learn ...
... a national healthcare,management and technology company, has renewed ... West Virginia to provide Revenue Cycle,Management (RCM), ASP ... physician groups., St. Mary,s Medical Center provides ... in several specialties. MED3OOO,s subsidiary,MED3OOO Health Solutions of ...
... CYT, MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will,hold a ... (Eastern Time) on Thursday, February 14, 2008. The Company,will report its results ... 14., DATE: ... ...
... Gentiva Health,Services, Inc. (Nasdaq: GTIV ), ... announced today that its CareCentrix(R),ancillary care benefit management ... homecare contract with CIGNA HealthCare, which will,provide for ... CIGNA,members through January 31, 2011. The extension amends ...
... employee benefit Increasing animal obesity, more and better pet care ... ... The insurance industry is,going to the dogs ... and cats., Officials ... friends and the growth trends for pet insurance are,only going to accelerate ...
... close ties with parents is obviously good for preschoolers, ... the preschoolers are better able to control their own ... , Thats the finding of a new study conducted ... in the January/February 2008 issue of the journal Child ...
Cached Medicine News:Health News:'Good bacteria' in women give clues for slowing HIV transmission 2Health News:'Good bacteria' in women give clues for slowing HIV transmission 3Health News:St. Mary's Medical Center Renews RCM & Technology With MED3000 2Health News:CryoCath to Hold First Quarter 2008 Conference Call and Webcast 2Health News:Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011 2Health News:Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011 3Health News:PetFirst: Pet Insurance To Be More Popular in 2008 2Health News:Close ties between parents and babies yield benefits for preschoolers 2
... peripheral nerve stimulator from B. Braun Medical. ... nerve stimulator functionality for over 10 years. ... available, a unique, under-the-glove hand held remote ... Dig. It allows the anesthesia provider operating ...
... Control allows hands-free operation in nerve locator ... 5.0 mA) with SoloStim provides a wide ... control when close to nerve., ,Supported ... block products, including the clinically proven ProBloc™ ...
... your investment., ,The Centiva/5 Critical Care Ventilator ... demands of the critical care environment. The Centiva ... combining a compact size with high levels of ... space around the patients bed and allows you ...
... Mesh Elastic is a lightweight and large pore ... mesh is able to adapt to all movements ... honeycomb like structure with the large pores enables ... The mesh is ideal for incisional hernia repair ...
Medicine Products: